ACRV vs GILD: Which Stock is Better?
Side-by-side comparison of Acrivon Therapeutics Inc and Gilead Sciences Inc in 2026
ACRV
Acrivon Therapeutics Inc
$1.96
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | ACRV | GILD | Winner |
|---|---|---|---|
| Market Cap | $61.85M | $154.03B | GILD |
| P/E Ratio | N/A | 19.22 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.7% | GILD |
Analyze ACRV
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACRV or GILD a better investment?
Comparing ACRV and GILD: Acrivon Therapeutics Inc has a market cap of $61.85M while Gilead Sciences Inc has $154.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACRV and GILD?
ACRV (Acrivon Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACRV or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACRV or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for ACRV.
Which company is more profitable: ACRV or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to 0.0% for ACRV.
Which is the larger company: ACRV or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.03B compared to $61.85M for ACRV.
Should I buy ACRV or GILD in 2026?
Both ACRV and GILD have investment merit. ACRV trades at $1.96 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACRV and GILD stock?
Key differences: Market Cap ($61.85M vs $154.03B), P/E Ratio (N/A vs 19.2x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.7%).